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Mucociliary clearance is composed of three components (i.e.,
mucin secretion, airway surface hydration, and ciliary-activity)
which function coordinately to clear inhaled microbes and other
foreign particles from airway surfaces. Airway surface hydration is
maintained by water fluxes driven predominantly by active
chloride and sodium ion transport. The ion channels that mediate
electrogenic ion transport are regulated by extracellular purinergic
signals that signal through G protein-coupled receptors. These
purinoreceptors and the signaling pathways they activate have
been identified as possible therapeutic targets for treating lung
disease. A systems-level description of airway surface liquid (ASL)
homeostasis could accelerate development of such therapies.
Accordingly, we developed a mathematical model to describe
the dynamic coupling of ion and water transport to extracellular
purinergic signaling. We trained our model from steady-state and
time-dependent experimental measurements made using normal
and cystic fibrosis (CF) cultured human airway epithelium. To
reproduce CF conditions, reduced chloride secretion, increased
potassium secretion, and increased sodium absorption were re-
quired. The model accurately predicted ASL height under basal
normal and CF conditions and the collapse of surface hydration
due to the accelerated nucleotide metabolism associated with CF
exacerbations. Finally, the model predicted a therapeutic strategy
to deliver nucleotide receptor agonists to effectively rehydrate the
ASL of CF airways.
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Failure to maintain airway surface liquid (ASL) homeostasisadversely impacts normal mucociliary clearance (MCC),
producing pulmonary diseases such as cystic fibrosis (CF) (1).
Chloride (Cl−) ion transport is disrupted in CF due to mutations
in the CF transmembrane regulator (CFTR), an anion channel
protein. In pulmonary epithelia, CFTR mutations result in a
reduced ability for transcellular Cl− secretion, reducing ionic
gradients that generate water flow (1). ASL rehydration, there-
fore, is a goal of CF therapies but remains difficult to achieve
due to the complexity of the regulatory systems that maintain
ASL homeostasis.
Experimental evidence suggests that a dominant mechanism
used by human airway epithelial cells to maintain ASL homeo-
stasis is the regulation of transepithelial ion fluxes by extracel-
lular purinergic signaling pathways (2, 3) (Fig. 1). The key
signaling molecules involved in the regulation of ASL volume are
ATP and adenosine (ADO). UTP also can initiate signaling.
However, because UTP concentrations in ASL are significantly
lower than ATP, UTP is not thought to play a major role in ASL
homeostasis. Qualitatively, ASL volume regulation can be un-
derstood as follows. As pulmonary surfaces become dehydrated,
increased concentrations of ATP and ADO are generated as a
function of cilia–mucus interactions (4), and these agonists ac-
tivate G protein-coupled receptors that regulate the conductance
of ion channels located in the apical cell membrane. This regu-
lation leads to a net flux of ions from the cell into the ASL,
creating an osmotic driving force that draws water into the ASL
and rehydrates pulmonary surfaces. Increased ASL volume re-
duces the concentrations of ATP, mucus, and ADO, modulating
signaling intensity.
Specific aspects of nucleotide regulation of ASL volume are
well-characterized. Extracellular ATP activates signaling via
P2Y2 purinoreceptors. In normal airway epithelia, activation
of P2Y2-R purinoreceptors cleaves phosphatidylinositol 4,5-
bisphosphate (PIP2), via a phospholipase C-dependent mecha-
nism, which inhibits by the epithelial sodium channel (ENaC)
that mediates Na+ absorption (5, 6). In parallel, the PIP2
cleavage product, IP3, stimulates a rise in intracellular Ca2+ and
Cl− secretion through CFTR and calcium-activated chloride
channels (CaCCs). Rises in intracellular calcium also activate
apical and basolateral potassium effluxes through calcium-
activated potassium channels (BKs and CaKCs, respectively)
(7, 8). ATP is released from airway epithelial cells onto pul-
monary surfaces via regulated vesicular and channel-mediated
pathways. Enzymes located on the airway surface modulate
ATP levels via the metabolism of extracellular ATP, which
produces a second agonist, ADO. This second agonist, ADO,
signals via the A2b receptor, leading to the generation of the
second messenger cAMP, which stimulates Cl− secretion via the
CFTR channel (3). Collectively, purinergic signals generate
transepithelial osmotic (ion) gradients that drive water fluxes
between the basolateral compartment and the airway surface (2,
9). In turn, this movement of water changes ASL volume and, at
Significance
The intrapulmonary airways conduct air to the alveoli and are
defended from inhaled pathogens by a highly regulated pro-
tective system of mucus, cilia, and liquid. In healthy lungs, a
well-hydrated mucus layer is cleared by cilia from airway sur-
faces. In cystic fibrosis (CF), airway surfaces are dehydrated,
leading to a failure of cilia-mediated mucus clearance and ac-
cumulation of pathogen-infected mucus. In this study, we
created a mathematical model of airway surface liquid regu-
lation in normal and CF cells and used the model to investigate
a potential therapy to rehydrate CF airways and restore proper
mucus clearance.
Author contributions: C.I.S., R.C.B., and T.C.E. designed research; C.I.S. performed re-
search; C.I.S., R.C.B., and T.C.E. analyzed data; and C.I.S., R.C.B., and T.C.E. wrote
the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
Freely available online through the PNAS open access option.
1To whom correspondence should be addressed. Email: conner.sandefur@uncp.edu.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1617383114/-/DCSupplemental.
E7272–E7281 | PNAS | Published online August 14, 2017 www.pnas.org/cgi/doi/10.1073/pnas.1617383114
least transiently, extracellular mucus and nucleotide concentrations.
Thus, ASL homeostasis is maintained by a complex system in
which purinergic signaling and ion/water transport are dynam-
ically coupled.
Mathematical models have proven to be useful tools for un-
derstanding and quantifying the different components of the
system that govern ASL homeostasis, including ion and water
transport and nucleotide regulation. Most available ion transport
models (10–13) focus on experiments performed in continuously
perfused Ussing chambers, where extracellular ion concentra-
tions are held constant and the ASL volume is maintained at a
level much larger than found in vivo. More recently, airway liq-
uid interface (“thin-film”) cultures have been used to study dy-
namic changes in ASL volume under conditions similar to those
found in human lungs (14). Most available models of ASL
transport (15–17) capture ion-driven water fluxes but do not
account for channel regulation or ASL volume by extracellular
signaling molecules.
As a step toward achieving a systems-level understanding of
ASL homeostasis we developed and validated a mathematical
model that coupled ion and water transport to purinergic sig-
naling. Specifically, our model coupled the conductance of
CFTR, ENaC, CaCC, CaKC, and BK channels to signaling by
extracellular nucleotides and nucleosides. To estimate model
parameter values we fitted our model to experimental data
from both normal and CF human airway epithelial cells. To
validate the model we used the model to predict changes in
ASL height by varying sodium absorption and chloride secre-
tion rates and removing nucleotide regulation of ion transport.
The model was then used to elucidate the episodic failure of
mucus transport in CF-associated clinical exacerbations and
develop strategies to restore airway surface hydration and
mucus clearance in CF.
Mathematical Model
Our model of dynamic ASL regulation couples ion and water
transport with purinergic signaling (Fig. 1). A description of the
model variables and their corresponding units is given in Table 1.
The starting point for our investigation was our previous model
of ion transport with dynamic cell volumes under conditions of
constant ASL volume (11). To model changes in both cellular
and ASL volume due to water fluxes driven by osmotic gradients
we updated the model to include the following equation for the
height of the apical compartment (HA, in meters):
d
dt
HA =VH2O
h
ppH2OðOSMA −OSMBÞ− paH2OðOSMC −OSMAÞ
i
,
[1]
where VH2O is the molar volume of water (in units of cubic meters
per mole), ppH2O and p
a
H2O are the paracellular pathway and apical
membrane permeabilities to water (in units of meters per sec-
ond, often denoted Pf), respectively, and OSMI is the osmolarity
of compartment I [ASL (A), basolateral (B), cellular (C), in units
of millimolar]. We assumed a constant surface area so that the
changes in ASL height related directly to the changes in ASL
volume. Cell volume was a function of basolateral and apical
water fluxes and is modeled as previously described (11).
The osmolarity of the ASL compartment (OSMA), was de-
fined as
OSMA =ΦA
½Na+A + ½K+A + ½Cl−A + ½OIA

, [2]
where ΦA is the osmotic coefficient of the ASL, ½Na+ A, ½K + A,
and ½Cl−A are the concentrations of sodium, potassium, and
chloride in the ASL, respectively, and ½OIA is the concentration
of all other ions and impermeable osmolytes within the ASL.
Compounds captured by ½OIA were assumed to reside only in
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Fig. 1. Schematic diagram of ASL regulation. Extracellular ATP and ADO dynamically regulate four apical membrane channel permeabilities, calcium-acti-
vated chloride channels (CaCCs), calcium-activated voltage-dependent potassium channels (BKs), epithelial sodium channels (ENaCs), and CF transmembrane
conductance regulator (CFTR) channels, and one basolateral membrane channel permeability, CaKCs. Changes in membrane permeabilities drive ion and
water movement, modulating ASL height. The directionality of ion flux across the membrane of a resting cell is denoted by arrows. ATP and ADO signaling
pathways via P2Y2 and A2b receptors are denoted in blue and dark green, respectively. Extracellular ATP metabolism is regulated by a network of membrane-
bound ectonucleotidases, which are denoted in pink and drawn above the cell due to space restrictions.
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the ASL and not transported into the cell or via the paracellular
pathway. The cellular compartment also contains an imperme-
able osmolyte as previously described (11). The cellular and ASL
impermeable osmolyte are each composed of two components:
(i) a negatively charged impermeable osmolyte representing neg-
atively charged constituents not specifically represented in the
model (e.g., bicarbonate and mucins), which maintain the elec-
troneutrality of the system, and (ii) an uncharged component,
which includes neutral compounds that contribute to the total
osmolarity of the compartment, such as glucose.
The activities of the three mobile ions within the ASL were
modeled using ion transport equations that capture the molar
abundance per unit surface area of each ion within the ASL:
d
dt
NAi = J
p
i − J
a
i , [3]
where Jpi and J
a
i are fluxes per unit surface area of ion i (Na
+, K+,
or Cl−) via the paracellular pathway and across the apical mem-
brane, respectively. The form of the flux term for an ion i moving
across the apical (a) or basolateral (b) membrane or through the
paracellular (p) pathway from compartment Y to X due to an
electrochemical gradient was described by Goldman’s constant
field equation (18):
JY→Xi =
pmi ziμ
eziμ − 1

aYi − a
X
i e
ziμ

, [4]
where pmi is the permeability of the apical membrane (p
a
i ) or
paracellular pathway (ppi ) (in units of meters per second), zi is
the ion valence of ion i, μ=FVm=RT is the nondimensional mem-
brane potential which is dependent on the Faraday constant (F,
in units of coulombs per mole), Vm =Va and Vm =Vb are the
apical or basolateral membrane potential (in units of volts), re-
spectively, R is the gas constant (in units of joules per mole ×
kelvin), T is the absolute temperature (in units of kelvin), and
ai is the activity of ion i in each compartment. Membrane poten-
tials (Vm), which are functions of ion currents, were calculated as
in ref. 11 with one exception. The paracellular ion current (Ip) is a
function of the paracellular fluxes of the three mobile ions cap-
tured by our model and was described by the following equation:
Ip =F

−JpNa+ + J
p
Cl+ − J
p
K+

. [5]
The permeability of the membrane (pmi ) is dependent on both
the number of ion channels in the membrane and the probability
that a given channel is open. The probability of a channel’s being
open is regulated by signaling pathways initiated by extracellular
ATP and ADO. To model the effect of purinergic signaling on
the permeabilities of ion channels we used phenomenological
mathematical relations based on Hill functions. Because these
general functional forms were sufficient for the model to capture
the experimental data, we did not investigate more complicated
mathematical relationships. Extracellular ATP activates chloride
secretion by increasing the permeability of apical CaCCs and the
CF transmembrane conductance regulator (CFTR). The perme-
ability due to CaCCs is described by the following expression:
pCaCC = pmaxCaCC
.h
1+

KATPCaCC
½ATPnATPCaCC
i
, [6]
where pCaCC is the apical permeability to chloride due to CaCC
(in units of meters per second), pmaxCaCC is the maximum CaCC
permeability (in units of meters per second), KCaCC is the con-
centration (in micromolar) of ATP at which the permeability is
half its maximum, and nCaCC is the Hill coefficient.
CFTR-mediated Cl transport is activated both by ATP and
ADO, which is formed by the hydrolysis of ATP by extracellular
enzymes. The permeability of the apical membrane to Cl− due to
CFTR channels was described by the following equation:
pCFTR = pmaxCFTR
.h
1+

KADOCFTR
½ADOnADOCFTR + KATPCFTR
½ATPnATPCFTR
i
,
[7]
where pCFTR is the apical permeability to chloride due to CFTR
channels (in units of meters per second), pmaxCFTR is the maximum
CFTR channel permeability (in units of meters per second),
KATPCFTR is the concentration (in micromolar) of ATP at which
the permeability is half its maximum in absence of ADO,
KADOCFTR is the concentration (in micromolar) of ADO at which
the permeability is half its maximum in absence of ATP, and
nATPCFTR and n
ADO
CFTR are the Hill coefficients. In simulations of CF,
pCFTR was assumed to be zero.
Apical membrane-localized calcium-activated voltage-dependent
potassium channels (BKs) transport K+ out of epithelial cells and
are regulated by ATP as follows:
pBK = pmaxBK
b1+ ðKBK=½ATRÞnBK c, [8]
where pBK is the apical permeability to potassium (in units of
meters per second), pmaxBK is the maximum apical potassium per-
meability (in units of meters per second), KBK is the concentra-
tion (in micromolar) of ATP at which the permeability is half its
maximum, and nBK is the Hill coefficient.
Table 1. Description of model variables
Variables and units Description
HC, m Cell height
NaC, mol/m
2 Cellular molar abundance of sodium ions per unit cell culture surface area
KC, mol/m
2 Cellular molar abundance of potassium ions per unit culture surface area
ClC, mol/m
2 Cellular molar abundance of chloride ions per unit culture surface area
Va, V Apical membrane potential
Vb, V Basolateral membrane potential
HA, m ASL height
NaA, mol/m
2 ASL molar abundance of sodium ions per unit cell culture surface area
KA, mol/m
2 ASL molar abundance of potassium ions per unit culture surface area
ClA, mol/m
2 ASL molar abundance of chloride ions per unit culture surface area
ATPA, μM ASL concentration of adenosine triphosphate
ADPA, μM ASL concentration of adenosine diphosphate
AMPA, μM ASL concentration of adenosine monophosphate
ADOA, μM ASL concentration of adenosine
INOA, μM ASL concentration of inosine
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The permeability of the apical membrane to sodium ions is pri-
marily governed by the epithelial Na+ channel (ENaC). In normal
airway cells, Na+ absorption is inhibited by extracellular ATP, via
activation of P2Y2 receptors, which hydrolyze phosphatidylinositol
PIP2, an anionic phospholipid demonstrated to regulate ion chan-
nels and transporters (5, 6). Additional evidence suggests ENaC
inhibition both by ADO-activated CFTR channels via protection
from proteolytic cleavage (19) and decreasing total available ENaC
protein levels (20). To describe the dynamic permeability of ENaC
in response to extracellular purinergic signals (pENaC) under normal
and CF equations, we used the following equations:
pNLENaC = p
max
ENaC
.h
1+
½ATPKATPENaC
nATPENaC + ½ADOKADOENaC
nADOENaCi
[9]
pCFENaC = p
max
ENaC
.h
1+
½ATPKATPENaC
nATPENaCi, [10]
where pNLENaC and p
CF
ENaC are the apical permeability to sodium due
to ENaCs in normal and CF airway cells (in units of meters per
second), respectively, pmaxENaC is the apical sodium permeability
through ENaCs in absence of extracellular ATP and ADO (in
units of meters per second), KATPENaC and K
ADO
ENaC are the concentra-
tions (in micromolar) of ATP and ADO, respectively, that gen-
erate half the maximum permeability, and nATPENaC and n
ADO
ENaC are
the Hill coefficients. In simulated CF cells, which lack ADO-
activated CFTR channels which normally inhibit ENaCs, we as-
sumed no ENaC inhibition via ADO.
Within the basolateral membrane, CaKCs are coupled to the
intracellular calcium concentration (8), which is regulated by
extracellular ATP. To describe this coupling, we used the fol-
lowing equation:
pCaKC = pmaxCaKC
b1+ ðKCaKC=½ATPÞnCaKCc, [11]
where pCaKC is the basolateral permeability to potassium (in units
of meters per second), pmaxCaKC is the maximum basolateral potas-
sium permeability due to CaKCs (in units of meters per second),
KCaKC is the concentration (in micromolar) of ATP at which the
permeability is half its maximum, and nCaKC is the Hill coefficient.
Also in the basolateral membrane is a non-CFTR Cl− con-
ductance. In addition, two types of transporters are localized to
the basolateral membrane that function to maintain membrane
potentials and intracellular ion activities: sodium–potassium
pumps and Na-K-2Cl cotransporters. The basolateral sodium–
potassium pump was modeled as previously described (11).
There are several available microscopically detailed models of the
Na-K-2Cl cotransporter (21–23), and we elected to implement the
model reported by Marcano et al. (22). The paracellular pathway
connects the ASL to the basolateral compartment and is perme-
able to Na+, Cl−, and K+ as well as water and was modeled as
previously described (11).
The descriptions of the dynamic concentrations of ATP and
ADO were based on a model of nucleotide regulation (24, 25)
that captures ATP dephosphorylation to ADP, AMP, and ADO
and ADO deamination to inosine. Additionally, the nucleotide
regulation model includes terms for ATP, ADP, and AMP release as
well as cellular uptake of ADO and inosine through CNT3 proteins.
The full set of ASL model equations and the parameter values and
estimation method are described in Tables S1–S3, Parameter Esti-
mation, and ASL Model Equations.
Results
Model Evaluation: Resting Normal Airway Cells. We performed pa-
rameter estimation by simultaneous fitting of the model to
steady-state and time-series data obtained from experiments with
normal and CF human airway epithelium (Experimental Data).
Our model showed good agreement with steady-state ion con-
centrations and ASL and cellular height data from both normal
and CF epithelium studied under static conditions where ATP
levels are low (<2 nM) and ADO levels ∼100–200 nM (Fig. 2
and Fig. S1).
In resting normal airway epithelium, a steady-state ASL height
of ∼7 μm is maintained through a complex balance of ion fluxes
across the cell membranes and through the paracellular pathway
[K+]A= 30 mM [Na
+]A= 116 mM [Cl
-]A= 105 mM
[K+]C= 105 mM [Na
+]C= 30 mM [Cl
-]C= 57 mM
HeightASL= 7.6 μm 
DFK+A= 8 mV DFNa+A= -63 mV DFCl-A= -11 mV 
DFK+B = 41 mV DFNa+B = -80 mV DF
Cl-
B = -19 mV 
DFK+P = 35 mV 
DFNa+p = -17 mV
DFCl-P = -16 mV 
[Cl-]A=  99 mM
[K+]C= 107 mM [Na
+]C= 27 mM [Cl
-]C= 60 mM
HeightASL= 3.5 μm 
DFK+A= 3 mV DFNa+A= -68 mV DF
Cl-
A= -15 mV
DFK+B = 41 mV DFNa+B = -83 mV DF
Cl-
B= -21 mV 
DFK+P = 38 mV 
DFNa+p = -16 mV
DFCl-P = -16 mV 
JBK JCaCCJCFTRJENaC
JCaKC
JKp
JNap
JClp JKp
JNap
JClp
JClb JClbJpump
Jco
JBK JENaC JCaCC
JCaKC
Jco Jpump
Normal Airways
-0
.0
1
2.
9
-0
.2
2
-2
.2 1.
0
-0
.1
4
-0
.0
1
2.
9
-0
.2
2
-0
.0
05
0.
65
-0
.9
8
-0
.0
1
-1
.4 0.
59
0.
41
-0
.0
9
-0
.0
05
0.
65
-1
.0
CF Airways
[K+]A= 33 mM [Na+]A= 116 mM ASL
CELL
BASOLATERAL
ASL
CELL
BASOLATERAL
0.
18
Fig. 2. Predicted ion fluxes and driving forces in resting normal (Left) and CF (Right) airway cells. Orange, yellow, and purple arrows denote movement of K+,
Na+, and Cl− ions, respectively, in units of micromoles per second × square meters. Ion electrochemical driving forces (DF) across the apical and basolateral
membranes and the paracellular pathway were calculated as the difference of the total potential of the given electrical membrane and equilibrium potentials
for the respective ion. Values to which the model were fit are denoted by square boxes. All other values are mean predictions of the model using
2,000 parameter sets obtained using a Monte Carlo method (detailed in Parameter Estimation).
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(Fig. 2, Left). At steady state, the Cl− ion cycle reflected secre-
tion into the ASL and basolateral uptake into the cell via the
Na-K-2Cl cotransporter. Our model predicts that the largest ion
flux across the normal apical cellular membrane is cellular Cl−
secretion onto the airway surface through CFTR channels. A
smaller Cl− efflux occurs via CaCCs. The net Cl− absorption at
the basolateral membrane results from the inward movement of
two chloride ions through Na-K-2Cl cotransporters (Jco) for ev-
ery one chloride ion excreted from the cell through basolateral
chloride channels (JbCl).
In normal cells, the dominant Cl− flux is balanced in part by a
net flux of Na+ cycling in the opposite direction as chloride.
Sodium is absorbed from the ASL into the cell through ENaCs
contained within the apical membrane. This absorption is bal-
anced by a net extrusion of Na+ from the cell across the baso-
lateral membrane. To achieve net Na+ extrusion, three
molecules of Na+ are extruded through the Na–K pump (Jpump)
for every one Na+ cation trafficked inwards through the Na-K-
2Cl cotransporter (Jco). The result is a net flux of Na
+ from the
cell to the basolateral compartment.
The model predicts that potassium ions, K+, cycle in the same
directions as chloride. Across the apical membrane, potassium is
secreted through BK channels at a rate less than that of the total
apical chloride flux. The activation of the BK conductance drives
apical membrane potential (Va) to hyperpolarize, increasing driving
forces for both Cl− secretion and Na+ absorption. To maintain
steady-state potassium concentrations in the ASL, potassium exits the
ASL via the paracellular pathway into the basolateral compartment.
Across the basolateral membrane, three modes of potassium
transport contribute to net potassium flux (i): conductive po-
tassium transport, (ii) Na–K ATPase pumps, and (iii) Na-K-2Cl
cotransporters. Net cellular potassium uptake is achieved by
uptake of K+ ions through the Na–K pump (Jpump) and the Na-
K-2Cl cotransporter (Jco), which would be at an excess in the cell
if not for the conductive extrusion of potassium out of the cell
through basolateral potassium channels (JbK).
Model Evaluation: Resting CF Airway Cells. In CF, the CFTR protein
is either functionally defective or is completely missing, depending
on the genetic mutation(s) in the CFTR gene. We first simulated
CF conditions by setting the CFTR Cl− permeability to zero.
However, this change to the model was not sufficient to reproduce
the experimentally observed steady-state conditions in CF human
airway epithelium. This observation is in agreement with a recent
mathematical model of CF airway cells in a perfused Ussing
chamber, which required increased apical Na+ and basolateral K+
and Cl− permeabilities, increased Na–K pump, and decreased Na-
K-2Cl cotransporter fluxes, in addition to absent CFTR Cl− fluxes
to model CF physiology (12). Accordingly, we performed pa-
rameter estimation keeping CFTR Cl− permeability at zero and
allowing all other parameters to change relative to normal con-
ditions to investigate which additional changes were necessary to
fit our CF ASL model to experimental data (Fig. 2, Right). The
steady-state height (volume) of the ASL under static conditions in
CF airways was about half that of normal airways but CF ASL
composition remained isotonic (Fig. 2, Right). As expected, the
model predicted that the net cycle of Cl− was reduced in CF cells.
This net reduction was the result of a reduced secretion of Cl−
across the apical membrane which was limited to secretion
through CaCCs in simulated CF cells (JCaCC, Fig. 2, Right). To
maintain a steady-state Cl− concentration in the ASL, the model
predicted reduced cellular Cl− secretion balanced by a reduced
flux of Cl− ions through the paracellular pathway. A steady-state
intracellular Cl− concentration was maintained by a decrease in
the net absorption of Cl− across the basolateral membrane. The
model predicted that conductive basolateral chloride secretion
modestly increased and cellular uptake of Cl− via Na-K-2Cl
cotransporters was reduced in CF, resulting in a reduced net
uptake of Cl− via the basolateral membrane.
In contrast to normal cells, our model predicted that Na+ flux is
the predominant apical membrane ion flux in CF cells, and that
this flux is greater in magnitude compared with normal cells. To
maintain a steady-state ASL Na+ concentration, the increased
sodium absorption drives an increased paracellular Na+ flux, as
more Na+ is moved from the basolateral compartment into the
ASL (JNap, Fig. 2, Right). In CF, the steady-state cellular concen-
tration of Na+ is maintained in normal ranges by an increased flux
through the Na-K ATPase pump, which moves a greater quantity
of Na+ out of the cell. Additionally, the inward flux of the Na-K-
2Cl cotransporter was reduced. The net result is an overall in-
crease in net sodium extrusion across the basolateral membrane.
The model predicts that potassium fluxes are also disturbed in
CF cells, although disturbances occur at relatively lower magni-
tudes compared with sodium and chloride fluxes. An increase in
potassium secretion across the apical membrane (JBK, Fig. 2,
Right) is predicted to offset in part the increased Na+ absorption.
The steady-state ASL concentration of K+ is balanced by an
increased paracellular K+ flux. To maintain a steady-state in-
tracellular K+ concentration, the net absorption of K+ across the
basolateral membrane was increased. This net increase was
predicted to primarily reflect the increase in Na–K pump activity
(Jpump, Fig. 2, Right), which drives K
+ into the cell.
Collectively, the model predicts that at rest CF cells exhibit re-
duced chloride secretion, increased sodium absorption and an in-
crease in potassium secretion, and a volume-depleted, isotonic ASL.
Model Validation. To test our model we simulated blocking ion
channels with pharmacological agents and compared those out-
puts to experimental data (Fig. 3). The contribution of Na+ and
Cl− transport to transepithelial potential (Vt) in NL and CF
airway cells has been measured by the administration of bume-
tanide or bumetanide and amiloride, respectively, and reported
to differ in normal vs. CF airway epithelia (Fig. 3). Bumetanide
blocks the basolateral sodium–potassium–chloride cotransporter
that provides cellular Cl− for secretion. To simulate bumetanide
block, the flux through the transporter was set to zero (Jmaxco = 0),
which reduced basolateral chloride uptake, lowered intracellular
chloride concentrations, and inhibited apical chloride secretion.
In normal cells, simulated block with bumetanide led to a small
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decrease in the transmembrane potential magnitude due to the
reduction in apical Cl− secretion, somewhat smaller than ob-
served experimentally (3) (Fig. 3A). In experiments with CF
airway epithelia with little apical Cl− secretion, blocking with
bumetanide had little impact on Vt, and the model accurately
captured these data (3) (Fig. 3B).
Amiloride blocks apical sodium channels, which was simulated
in our model by setting the apical ENaC sodium permeability to
zero (pNLENaC = 0 or p
CF
ENaC = 0). Amiloride exposure alone can
underestimate the block of Na+ absorption in normal cells be-
cause increases in apical driving forces for Cl− are produced that
generate accelerated Cl− secretion. Accordingly, the effects of
amiloride on Na+ transport are experimentally tested by expos-
ing cells to bumetanide (to limit induced Cl− secretion) followed
by amiloride. The model captured in normal airway epithelia the
observed experimental changes in transepithelial electrical po-
tential difference via “blocking” with amiloride and bumetanide
(Fig. 3A, blue). Sodium absorption is the major contributing
variable to Vt in CF cells, and in accordance with experiments,
the change in Vt after simulated block with amiloride was much
greater in CF relative to normal airway epithelia (Fig. 3B, red).
Model evaluation of regulation of ASL volume by extracellular nucleotide/
nucleosides. To evaluate the parameters in the expressions cou-
pling purinergic signals in the ASL to ion transport we fitted the
model first to experiments in which nucleotide concentrations
were reduced. When 20 μL of isotonic fluid, such as PBS, is
applied to human airway epithelial cells under “thin-film” (7 μm)
conditions, the ambient 1 μL of ASL is acutely diluted/expanded,
following which airway epithelia rapidly absorb the added fluid.
The model reproduced the experimental maneuver (Fig. 4A) and
described volume-induced dilution of ATP (Fig. 4B) and ADO
concentrations in the ASL (Fig. 4C) following volume (PBS)
addition. Dilution of ATP/ADO acutely increased the Na+ per-
meability and flux absorption through ENaCs (Fig. 4 D and E),
decreased Cl− secretion, and generated osmotic gradients fa-
voring fluid absorption from the ASL into the cell and, ulti-
mately, to the basolateral compartment to restore the pre-PBS
ASL height of 7 μm (Fig. 4A, solid blue line).
We also validated the model by testing for the effects of puri-
noreceptor activity on the pattern of ion transport. It is thought
that normal airway epithelia under resting conditions metabolize
most ATP to ADO and use ADO to maintain the 7-μm ASL
heights. This notion has in part arisen from the observations that
(i) ADO is the major purine nucleoside in ASL under static
conditions and (ii) blocking activation of A2b receptors by ADO
using eight-SPT reduced ASL height in normal airway epithelia
(26). We simulated A2b receptor block by increasing the
Michaelis–Menten constants associated with ADO activation. In
the “absence” of ADO activation of A2b and consequent absence
of CFTR activation and ADO inhibition of ENaC, the model
captured the more rapid rate of absorption and reduced steady-
state ASL height observed experimentally in normal cells follow-
ing A2b blocker addition (Fig. 4A, dotted blue line).
Modeling in vivo ASL conditions. In vivo there is phasic motion during
tidal breathing that imposes stresses on airway surfaces that are
not captured by static cell culture conditions. However, tidal
breathing can be mimicked in vitro via experimental systems that
apply cyclic compressive stress (CCS) to cultures (3). These ex-
periments have shown CCS-induced shear stresses (i) increase the
rate of ATP release into the ASL, (ii) increase ASL volume se-
cretion via activation of CFTR and CaCCs and inhibition of
ENaCs, and (iii) that the response of ASL height to CCS quanti-
tatively differs between NL and CF airway epithelia. We simulated
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addition of 20 μL PBS followed by 3 h of CCS-mediated shear
stress by increasing the rate of ATP release to a rate that achieves
a concentration of 40 nM ATP in ASL. This ATP level closely
mimics the concentration of ATP that was experimentally mea-
sured after CCS shear stress was delivered at a magnitude mim-
icking that experienced during normal tidal breathing (26).
The model accurately captured steady-state changes in ASL
volume (height) after isotonic fluid addition under CCS condi-
tions in normal and CF cells (Fig. 5). At time 0, upon addition of
PBS, nucleotide concentrations are depleted. The model then
predicts that CCS-induced increases in extracellular ATP con-
centration (Fig. 5B) are sufficient to activate Cl− secretion by
CFTR (Fig. 5C) and CaCCs (Fig. 5D) and inhibit Na+ absorption
by ENaCs (Fig. 5E) in normal cells. Additionally, apical potas-
sium channels were activated, increasing K+ secretion (Fig. 5F).
After a few minutes, a fraction of the increased ATP was hy-
drolyzed to ADO (Fig. 5B), which, in normal cells, further ac-
tivated CFTR (Fig. 5C), resulting in additional Cl− secretion.
The steady-state effect of increased ATP release due to CCS was
to maintain ASL heights of ∼14 μm in normal epithelia. Based
on recent biophysical models of the airway surface compartment,
we predict the liquid in excess of 7 μm on normal epithelial
surfaces will be “stored” in the mucus layer (27).
CCS postisotonic fluid addition resulted in a steady-state ASL
height in CF epithelia of 7 μm (Fig. 5G). The smaller ASL height
in CF than in normal epithelia reflected the absence of regulated
CFTR Cl− secretion and the increased rate of Na+ net absorption.
Importantly, the CCS-induced increase in ATP release rates
produced, via activation of CaCCs, an ASL height in CF epithelia
(∼7 μm) consistent with adequate hydration to sustain mucus
transport. These results are consistent with data that decreased
MCC in CF is heterogeneous, with many areas of the CF lung
exhibiting apparently normal mucus transport in areas where
airflow is preserved and CCS-induced ATP release operative (28).
We tested the notion that the reduced ASL height response to
CCS reflected the absence of CFTR Cl− secretion by running
simulations in normal cells under CCS-exposed CFTR channel
inhibitors (−CFTR, Fig. 5A). Under these conditions, the ASL
height fell to ∼7 μm, mimicking CF cells under CCS. This de-
crease in normal airway ASL height under CCS conditions
reflected the absence of CFTR-mediated Cl− secretion across
the apical membrane coupled to persistent ATP-mediated
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inhibition of sodium absorption. To test the requirement for Cl−
secretion to maintain ASL height of 7 μm in CFTR-blocked
normal cells we simulated block of both CaCC and CFTR
channels (−CFTR and −CACC, Fig. 5A). The resulting ASL
height was 3 μm. Note that CCS did inhibit ENaC (Fig. 5E) via
ATP–P2Y2 receptor mechanisms, but the resulting reduction in
Na+ absorption was not sufficient to overcome the complete block
of Cl− secretion in normal cells with CaCC and CFTR channel
blockers. Accordingly, blocking all apical Cl− secretion in normal
cells after isotonic fluid addition under CCS produced an ASL
height below steady-state values observed in static normal cultures.
The result occurred despite persistent ENaC inhibition, demon-
strating the need for some Cl− secretory capacity to generate ASL.
We next tested the role of CaCC in maintaining the ASL height
in CCS-exposed CF cells. In simulated CF cells under CCS, CFTR
channel inhibitors did not alter ASL height compared with CCS
alone, as expected (Fig. 5G). In the presence of both the CFTR
and CaCC inhibitors, a large reduction in ASL volume resulted,
reflecting a complete block of apical Cl− secretion.
Simulation of CF pulmonary exacerbations. It has been observed ex-
perimentally that respiratory tract viral infections (e.g., respiratory
syncytial virus up-regulates extracellular ectonucleotidases) reduce
ASL ATP concentrations and reduce ASL volume in cultured CF
epithelia under CCS conditions (26). Based on these findings, it
has been speculated that local virally induced ATP depletion, ASL
collapse, and failed mucus clearance may trigger CF lung disease
exacerbations (29). Accordingly, we simulated the effects of in-
duced ecto-ATPase up-regulation by the addition of increased
ectonucleotidase activity to our model.
Apyrase is an ectonucleotidase that can be experimentally added
to ASL to increase the rate of ATP conversion to AMP. Notably,
apyrase depletes CF airway epithelial ASL of ATP and reduces
basal ASL height under CCS conditions (26). We simulated apyrase
additions to ASL by increasing the Vmax values related to ATP and
ADP hydrolysis. In simulated CF cells under basal CCS conditions
(Fig. 6A, red bar), the height of the ASL decreased with apyrase
treatment (Fig. 6A, green bar), as observed experimentally. As CF
cells lack both ADO-mediated signaling of CFTR activation and
ENaC inhibition observed in normal cells, they are particularly
vulnerable to depletion of the sole active purinoceptor agonist,
ATP. Thus, the model captured a potential mechanism for the
collapse in MCC that may be a feature of some virus-induced
CF exacerbations.
Rehydration Mechanism for CF Airways. Based on the observation
that CCS-induced increases in ATP release produce ASL heights
in CF airway epithelia (7 μm) sufficient to mediate normal
mucus transport (Fig. 5G), aerosolized nucleotides have been
proposed as therapy for CF patients. To slow the hydrolysis of
nucleotides, and prevent ADO formation, a slowly hydrolyzing
pyrimidine-based P2Y2 receptor agonist, Denufosol, was de-
veloped (30, 31). To achieve drug concentrations on lower airway
surfaces sufficient to activate P2Y2 receptors for approximately
8 h after administration, high concentrations of Denufosol
(15 mg/mL) were delivered from nebulizers over 15-min inter-
vals. After promising phase-II studies, Denufosol was not found
to have sufficient clinical benefit for approval. Subsequent
studies suggested that the high initial deposited dose caused
P2Y2-receptor desensitization, limiting airway surface hydration
to short intervals (4). This observation raised the question of
whether Denufosol administered over a prolonged period, at a
dose designed to achieve activity but lower than P2Y2-receptor
desensitizing concentrations, would restore the ASL height.
Recent advances in drug delivery technology have led to trans-
nasal aerosal delivery devices, which allow for administration of
drugs through nasal passages over an extended period (e.g., while a
patient is sleeping). To test whether low-dose, prolonged transnasal
aerosol delivery of Denufosol might be therapeutically effective, we
first developed an ordinary differential equation model of Denu-
fosol metabolism and transnasal delivery to the airway surface
(Table S4 and Denufosol Model). We used this model to predict the
quantity of Denufosol in the transnasal delivery device necessary to
maintain 100 nM of drug on the airway surface, which is close to the
EC50 value of P2Y2 receptor and should avoid desensitization (31)
(Fig. 6B). The concentration of a Denufosol solution in the trans-
nasal delivery device, with a delivery rate of 32 μL/min and a de-
position efficiency of 40% into a 10-mL ASL volume, required to
achieve this concentration was calculated to be 5 μM.
Next, we asked how this prolonged administration of low-dose
Denufosol would impact ASL height in simulated normal and CF
airway surfaces. For this simulation, we coupled our model of
Denufosol delivery to our model of purinergic regulation of ASL
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height by coupling the Denufosol concentrations to permeability
equations similar to ATP (i.e., in Eqs. 6–11, [ATP] was replaced by
[ATP] + [Denufosol]). Simulated administration of a low-dose
continuous Denufosol (Fig. 6B) modestly raised the ASL height
in normal epithelial cells (Fig. 6C, blue line) while restoring ASL
height in CF epithelial cells (Fig. 6C, red line). CF airway surfaces
are heterogeneous with respect to disease expression, meaning the
volume of ASL in vivo varies within the pulmonary system. Our
model predicts that a P2Y2 receptor-agonist therapy is effective on
CF cells but would not likely flood regions with more normal
ASL heights.
Discussion
Airway epithelia dynamically regulate ASL volume to optimize
mucus transport by balancing hydration of secreted mucus with
minimization of ASL volume (height) to reduce airflow re-
sistance. A systems-level understanding of ASL homeostasis re-
quires a model that accurately describes the dynamic coupling
between purinergic signaling and ion/water transport. This dy-
namic regulation of ASL volume by soluble purinergic mediators
contained within ASL has not been previously modeled.
Accordingly, we developed a model of airway liquid homeostasis
regulated via purinergic signaling. Notably, the permeabilities of
sodium, chloride, and potassium ions were coupled to the extracel-
lular concentrations of ATP and ADO. Model parameters were
estimated by fitting the model to experimental data from ATP- and
ADO-mediated changes to ASL height in human bronchial epithe-
lial cells from normal subjects and CF patients. The model was
validated by comparing model simulations to experimental data
describing the effects of ATP/ADO dilution and ENaC, cotrans-
porter, and A2b receptor block. Our model is consistent with the
experimental observations that ATP and ADO signaling modulates
Na+ and Cl− ion transport and regulates surface liquid volume
(height) on airway epithelial surfaces (26).
With respect to disease pathogenesis, our model predicted that
an isotonic ASL of ∼7 μm in normal and ∼3 μm CF cells under
resting (static) conditions was associated with low extracellular
ATP (2 nM) and higher ADO (∼200 nM) concentrations. Both
decreased Cl− secretion and increased Na+ absorption contributed
to the decrease in ASL height in CF. Potassium secretion across
the apical and basolateral membranes via conductive transport
was also predicted to be disrupted in CF cells. Importantly, the
model reproduced the low ASL volume (“dehydration”) without
significant perturbation of the transepithelial potential difference
that has been demonstrated to be characteristic of CF bronchial
epithelia in in vitro conditions (3).
Under conditions reprising those in vivo, for example phasic
motion and associated mechanical forces/shear-induced ATP
release, ASL height rose in normal and, significantly less, CF
airway epithelia, as observed in in vitro experiments (26). Both
responses reflected increased ATP release. In normal epithelia,
the ATP activation of P2Y2 and ADO activation of A2b recep-
tors produced inhibition of ENaC, activation of CaCCs and
CFTR, and increased ASL volume. In CF epithelia, the smaller
increase in ASL height in response to phasic motion reflected
the sole dependence of ASL height on ATP-P2Y2 receptors, and
not ADO-A2b-CFTR pathways. However, the ASL effects were
sufficiently large in CF to predict relatively normal mucus
transport as observed in “normal” regions of CF lungs (28).
The rate of loss of lung function in CF is a function of the
frequency and severity of acute exacerbations. The triggers for
exacerbations are multiple but are likely dominated by viral in-
fections. We have speculated that acute exacerbations reflect
failure of mucus transport in areas of viral infection (29). The
breakdown of mucus transport reflects the virus-induced up-
regulation of ecto-ATPases, reduction in ATP levels, and ASL
depletion (26). Our model data quantitatively mimicked this sce-
nario and emphasize that the increased severity of viral infections
in CF vs. normal individuals reflects the sole dependence of ASL
height regulation on ATP in CF, whereas in normal subjects the
metabolic product of ectoenzymes (i.e., ADO) is also active in
maintaining ASL height during infection. This sole dependence on
ATP signaling for ASL height regulation describes in part the
vulnerability of CF airways to viral insults.
Finally, we simulated the therapeutic strategy of delivery of a
low-dose, prolonged aerosol administration of a slowly hydro-
lyzed P2Y2 receptor binding compound, Denufosol. Clinical
trials of Denufosol used high doses (concentrations) delivered to
the lungs for short time periods via a jet nebulizer and did not
produce positive results in phase-3 trials due to suspected P2Y2
receptor desensitization (4, 30, 32). Our model predicts that
transnasal delivery of a low dose of Denufosol over prolonged
intervals to CF subjects can activate the P2Y2 receptors at a
concentration sufficient to increase ASL height but not produce
P2Y2 receptor desensitization (31). Collectively, our model of
ASL homeostasis suggests prolonged delivery of a low dose of a
slowly hydrolyzing P2Y2 agonist such as Denufosol as a possible
treatment avenue for patients with CF.
In summary, we have developed an integrated model of
normal human ASL homeostasis that incorporates both the ion
transport and nucleotide/nucleoside pathways important in
this process. The model accurately captured experimental data
from normal and CF airway epithelia to predict ASL volume
and, hence, mucus clearance in health and disease. Our model
allows computational analysis of complex regulatory interac-
tions involved in airway surface hydration and should provide
a starting point for developing novel strategies for treating
lung disease.
Methods
Our model consists of 15 differential equations (ASL Model Equations) [and
23 differential equations for P2Y2-agonist simulations (Denufosol Model)].
All simulations were performed in MATLAB using the ode15s solver (33). The
model consists of 47 fixed parameters obtained from the literature (Table
S1). Values for the free parameters [17 for normal cells and 13 for CF cells
(Table S1)] were obtained by sampling parameter space using a Monte Carlo
method (11, 34). The goodness of fit between the model and the experi-
mental data were determined by calculating the sum of squares differences
between the experimental data and model simulations for each candidate
parameter set (Figs. S2 and S3). Experimental data for ion transport and ASL
homeostasis used for model fitting were obtained from the literature; de-
tails are in Experimental Data.
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